Brief: Celyad Oncology FY Operating Loss Widens To EUR 26.4 Million

Celyad Oncology SA

25/03/2022 07:43

March 25 (Reuters) - Celyad Oncology SA  CYAD.BR :
    * REPORTED ON THURSDAY FULL YEAR 2021 FINANCIAL RESULTS AND
RECENT
BUSINESS HIGHLIGHTS
    * CASH POSITION OF EUR 30.0 MLN ($34.0 MLN) AS OF DEC 31,
2021
    * FY NO REVENUE VS NO REVENUE YR AGO
    * FY OPERATING LOSS EUR 26.4 MLN VS LOSS EUR 17.0 MLN YR AGO
    * FY LOSS FOR THE YEAR EUR 26.5 MLN VS LOSS EUR 17.2 MLN YR
AGO

Source text for Eikon:  ID:nBw1P6Rdta 
Further company coverage:  CYAD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))